EcoDrugPlus

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSPAG00000005236
Gene Symbol: FDFT1
3 Cross references
69 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSSPAG00000022971
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSPAG00000009253
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSSPAG00000015365
Gene Symbol: LOC103353638
4 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSSPAG00000005860
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSSPAG00000020969
Gene Symbol: FGFR3
3 Cross references
193 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSSPAG00000018550
Gene Symbol: FLT4
3 Cross references
193 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSSPAG00000020506
Gene Symbol: FOLH1B
3 Cross references
339 Possible Orthologues:

Folate Receptor Alpha-Like

Ensembl ID : ENSSPAG00000020314
Gene Symbol: LOC103371929
3 Cross references
436 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSSPAG00000017661
Gene Symbol: LOC103369304
2 Cross references
338 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSSPAG00000006162
Gene Symbol: FRK
3 Cross references
202 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSSPAG00000010368
Gene Symbol: GLA
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).